- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06250608
Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.
Evaluation of Cerebral Oxygen Saturation(rSO2) Measurements Between Frontal Lesion Area and Normal Area of Brain by Pulse Oximetry(NIRSITX) Using Near-infrared Spectroscopy in Acute Ischemic Stroke Patients, Prospective, Single-center, Non-randomized, Open-label, Exploratory Clinical Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tae Jung Kim
- Phone Number: 82-2-2072-1810
- Email: ttae35@gmail.com
Study Contact Backup
- Name: Seojin Pyo
- Phone Number: 82-10-3892-3840
- Email: sjpyo@obelab.com
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
Contact:
- Tae Jung Kim
- Phone Number: 82-2-2072-1810
- Email: ttae35@gmail.com
-
Contact:
- Young Joo Kim
- Phone Number: 82-10-8744-9163
- Email: biokyj@hanmail.net
-
Principal Investigator:
- Sang-Bae Ko
-
Sub-Investigator:
- Tae Jung Kim
-
Sub-Investigator:
- Giljun Suh
-
Sub-Investigator:
- Woon Yong Kwon
-
Sub-Investigator:
- Taegyun Kim
-
Sub-Investigator:
- Yoon Sun Jung
-
Sub-Investigator:
- Hayoung Kim
-
Sub-Investigator:
- Hee Su Park
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults over age 19
- Patients diagnosed with acute ischemic stroke within 7 days of symptom onset
- Patient's condition confirmed to have an acute ischemic stroke and also brain blood vessels condition confirmed through brain imaging such as Brain CT/CTA/CT perfusion and Brain MRI/MRA
- Patients voluntarily agree to participate and scheduled to participate in this clinical trial
- Patients willing to comply with the clinical trial protocol
Exclusion Criteria:
- Patients without brain imaging result
- Patients diagnosed with jaundice (hyperbilirubinemia) with abnormal skin color - Patients who find it difficult to wear medical devices for clinical trial on their foreheads
- Patients who has skull fractures of external shape not maintained normal
- Patients who does not agree to participate in this clinical trial
- Patients who are currently participating in another clinical trial or have participated in another clinical trial within 30 days of the screening date
- Patients who is determined from investigator that participating is inappropriate because it may affect the results of the clinical trial or ethically
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Acute ischemic stroke patients
|
It is a device that non-invasively continuously monitors blood oxygen saturation (rSO2) in localized areas of the brain.
This device is attached to patients with symptoms suspected of stroke or diagnosed with stroke to continuously monitor the level of oxygen supply to the brain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of rSO2 values obtained from NIRSITX, a medical device for clinical trials, between the frontal lobe on the side with brain lesions and the frontal lobe on the contralateral side.
Time Frame: Baseline and follow-up (24 hours later)
|
The number of study subjects, mean, standard deviation, median, minimum, and maximum are presented as descriptive statistics for the difference and rate of change in rSO2 values obtained from medical equipment for clinical trials between the frontal lobe on the side with the brain lesion and the frontal lobe on the contralateral side.
The statistical significance of the change in rSO2 values between two areas is tested using the t-test or Wilcoxon test.
|
Baseline and follow-up (24 hours later)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OBE-KMT22-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Investigators must keep confidential all information related to the clinical trial protocol provided by the sponsor or clinical trial monitor. However, exceptions are made when disclosure is requested by the Institutional Review Board, research subjects, or health authorities pursuant to laws or related regulations.
Personal information of research subjects who participated in clinical trials will be used for up to 6 months after the end of clinical trials, and the collected information will be appropriately managed in accordance with the Personal Information Protection Act. This personal information is not provided to anyone other than the tester.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Ischemic Stroke Patients
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalCompletedCancer Patients First-ever Acute Ischemic StrokeUnited States
-
Capital Medical UniversityCompletedAcute Coronary Syndrome | Elderly Patients | Acute Ischemic StrokeChina
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Craig AndersonJohns Hopkins University; Genentech, Inc.; The George Institute for Global Health...RecruitingAcute Ischemic Stroke Patients Receiving Reperfusion TherapyAustralia, United Kingdom, United States, Chile, China, Malaysia, Mexico
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Dongzhimen Hospital, BeijingThe Second Hospital of Hebei Medical University; Peking University Third Hospital and other collaboratorsRecruitingStroke, Ischemic | Stroke, Acute | Acute Ischemic StrokeChina
-
University of MiamiTemporarily not availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)CompletedAcute Ischemic Stroke (AIS)United States
-
Beijing Tiantan HospitalRecruitingIschemic Stroke, AcuteChina
-
Shanghai Yueyang Integrated Medicine HospitalRecruitingIschemic Stroke, AcuteChina
Clinical Trials on Pulse oximeter, NIRSITX
-
William Beaumont HospitalsCompletedAsthma in Children | Respiratory Disease | Bronchiolitis Acute | Pneumonia in ChildrenUnited States
-
Nihon KohdenUniversity of California, San FranciscoCompleted
-
Nihon KohdenUniversity of California, San FranciscoActive, not recruiting
-
The Lifebox FoundationJohns Hopkins University; University College, London; Bill and Melinda Gates... and other collaboratorsCompletedPneumonia in Children | Measurement of Peripheral Oxygen SaturationUnited Kingdom, Bangladesh, Malawi
-
Belun Technology Company LimitedClinimark, LLCCompleted
-
Movano HealthUniversity of California, San FranciscoCompleted
-
Nihon KohdenUniversity of California, San FranciscoActive, not recruiting
-
Flashback TechnologiesDuke UniversityCompleted
-
Nonin Medical, IncClinimark, LLCCompleted